tiprankstipranks
Zeo ScientifiX (ZEOX)
OTHER OTC:ZEOX
US Market

Zeo ScientifiX (ZEOX) Stock Price & Analysis

42 Followers

ZEOX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $3.54
Previous Close$2.3
Volume6.49K
Average Volume (3M)5.48K
Market Cap
$14.56M
Enterprise Value$14.50M
Total Cash (Recent Filing)$746.00K
Total Debt (Recent Filing)$685.00K
Price to Earnings (P/E)
Beta1.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding6,332,419
10 Day Avg. Volume8,055
30 Day Avg. Volume5,479
Standard Deviation0.43
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-9.24
Price to Sales (P/S)13.88
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.94
Enterprise Value/Gross Profit3.58
Enterprise Value/Ebitda-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ZEOX FAQ

What was Zeo ScientifiX’s price range in the past 12 months?
Zeo ScientifiX lowest stock price was <$0.01 and its highest was $3.54 in the past 12 months.
    What is Zeo ScientifiX’s market cap?
    Currently, no data Available
    When is Zeo ScientifiX’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Zeo ScientifiX’s earnings last quarter?
    Currently, no data Available
    Is Zeo ScientifiX overvalued?
    According to Wall Street analysts Zeo ScientifiX’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Zeo ScientifiX pay dividends?
      Zeo ScientifiX does not currently pay dividends.
      What is Zeo ScientifiX’s EPS estimate?
      Zeo ScientifiX’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Zeo ScientifiX have?
      Zeo ScientifiX has 6,332,419 shares outstanding.
        What happened to Zeo ScientifiX’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Zeo ScientifiX?
        Currently, no hedge funds are holding shares in ZEOX
        ---

        Zeo ScientifiX Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Positive
        20 days / 200 days
        Momentum
        20809.09%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        -42.06%
        Trailing 12-Months

        Company Description

        Zeo ScientifiX

        Biotech Products Services & Research, Inc. engages in the provision of regenerative anti-aging medicine. It focuses on the supply of biologically processed cellular and tissue-based products developed from internally-based research and development activities and/or from other regenerative medicine-related products. It operates through the Referral and Product Sales and MMTC Activities segments. The Referral and Product Sales segment provides anti-aging and cellular therapy patient marketing and product sales. The MMTC Activities segment refers to the operation of Medical Marijuana Treatment Centers. The company was founded by John Goodhew on August 8, 2011 and is headquartered in Miami, FL.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Ocugen
        Oncolytics Biotech
        Ocular Therapeutix
        Omeros
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis